First Citizens Bank & Trust Co. Sells 1,152 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

First Citizens Bank & Trust Co. lowered its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 1.5% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 73,482 shares of the company’s stock after selling 1,152 shares during the period. First Citizens Bank & Trust Co. owned approximately 0.06% of Henry Schein worth $5,085,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Cromwell Holdings LLC lifted its stake in Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after acquiring an additional 170 shares during the period. Versant Capital Management Inc lifted its stake in shares of Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after purchasing an additional 335 shares during the period. City State Bank bought a new position in shares of Henry Schein in the 4th quarter worth approximately $55,000. Farther Finance Advisors LLC lifted its stake in shares of Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after purchasing an additional 346 shares during the period. Finally, Livforsakringsbolaget Skandia Omsesidigt lifted its stake in shares of Henry Schein by 282.1% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock worth $109,000 after purchasing an additional 1,100 shares during the period. Institutional investors own 96.62% of the company’s stock.

Insider Activity

In related news, COO Michael S. Ettinger sold 12,240 shares of the firm’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 1.14% of the company’s stock.

Analyst Ratings Changes

HSIC has been the topic of several recent research reports. Barrington Research reiterated an “outperform” rating and issued a $82.00 price objective on shares of Henry Schein in a research note on Wednesday, November 6th. Mizuho assumed coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective on the stock. Evercore ISI increased their target price on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Jefferies Financial Group increased their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a report on Thursday. Finally, Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their target price for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Seven analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Henry Schein currently has an average rating of “Moderate Buy” and a consensus target price of $79.30.

Henry Schein Stock Up 0.3 %

NASDAQ HSIC opened at $74.97 on Friday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The company has a market capitalization of $9.35 billion, a P/E ratio of 30.85, a P/E/G ratio of 2.04 and a beta of 0.89. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.63. The stock has a 50 day moving average price of $72.99 and a 200-day moving average price of $71.01.

Henry Schein (NASDAQ:HSIC) last posted its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s quarterly revenue was up .4% compared to the same quarter last year. During the same period in the prior year, the company earned $1.32 EPS. As a group, equities analysts predict that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.